Inappropriate data and measures lead to questionable conclusions

Simple item page
dc.contributor.authorSpielmans, G.
dc.contributor.authorJureidini, J.
dc.contributor.authorHealy, D.
dc.contributor.authorPurssey, R.
dc.date.issued2013
dc.descriptionLetter to the Editor
dc.description.statementofresponsibilityGlen I. Spielmans, Jon Jureidini, David Healy, Robert Purssey
dc.identifier.citationJAMA Psychiatry, 2013; 70(1):121-122
dc.identifier.doi10.1001/jamapsychiatry.2013.747
dc.identifier.issn2168-622X
dc.identifier.issn1538-3636
dc.identifier.orcidJureidini, J. [0000-0001-7585-2660]
dc.identifier.urihttp://hdl.handle.net/2440/80172
dc.language.isoen
dc.publisherAmerican Medical Association
dc.rights©2013 American Medical Association. All rights reserved.
dc.source.urihttps://doi.org/10.1001/jamapsychiatry.2013.747
dc.subjectHumans
dc.subjectCyclohexanols
dc.subjectFluoxetine
dc.subjectSuicide
dc.subjectDepressive Disorder, Major
dc.subjectRandomized Controlled Trials as Topic
dc.subjectSelective Serotonin Reuptake Inhibitors
dc.titleInappropriate data and measures lead to questionable conclusions
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Psychiatry publications